Alicia F. Okines
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 24, 2021
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Journal: European radiology
Published: October 04, 2021
De-escalation of adjuvant chemotherapy for HER2 negative breast cancer.
Journal: The Lancet regional health. Western Pacific
Published: May 17, 2021
Genomic loss of heterozygosity and survival in the REAL3 trial.
Journal: Oncotarget
Published: August 01, 2018
T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial.
Journal: Reviews on recent clinical trials
Published: April 28, 2017
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Journal: The Lancet. Oncology
Published: August 31, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026